Marks-Min ZMC with B12 New Zealand - English - Ministry for Primary Industries

marks-min zmc with b12

boehringer ingelheim animal health new zealand limited - vitamin b12; copper; manganese; zinc - vitamin b12 1.4 g/litre; copper 10 g/litre; manganese 6.7 g/litre; zinc 26.7 g/litre - parenteral nutrient/electrolyte

CEFA-LAK SUSPENSION Canada - English - Health Canada

cefa-lak suspension

boehringer ingelheim animal health canada inc. - cephapirin (cephapirin sodium) - suspension - 200mg - cephapirin (cephapirin sodium) 200mg - cattle

DRY-CLOX GEL Canada - English - Health Canada

dry-clox gel

boehringer ingelheim animal health canada inc. - cloxacillin (cloxacillin benzathine) - gel - 500mg - cloxacillin (cloxacillin benzathine) 500mg - cattle

CEFA-DRI SUSPENSION Canada - English - Health Canada

cefa-dri suspension

boehringer ingelheim animal health canada inc. - cephapirin (cephapirin benzathine) - suspension - 300mg - cephapirin (cephapirin benzathine) 300mg - cattle

Recombitek C4/CV Each dose 1.0 mL of vaccine contains the following through expiration: Active Ingredients: Canarypox/ Canine distemper virus recombinant, CP258, Rentschler/Onderstepoort strain, at least ................................................................................... >106.4TCID50 Canine adenovirus type 2, Toronto A/26/61 strain, at least ...................... >104.3 TCID50 Canine parvovirus, 780916 strain, at least ............................................. >103.3 FAID50 Canine parainfluenza virus, D-008 strain, at least ................................... >103.9 TCID50 Canine coronavirus, K-378/51 strain, at least........................................... >103.6 TCID50 "TCID-Tissue Culture Infective Dose "FAID- Fluorescent Antibody Infective Dess Lyophilized Powder for Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

recombitek c4/cv each dose 1.0 ml of vaccine contains the following through expiration: active ingredients: canarypox/ canine distemper virus recombinant, cp258, rentschler/onderstepoort strain, at least ................................................................................... >106.4tcid50 canine adenovirus type 2, toronto a/26/61 strain, at least ...................... >104.3 tcid50 canine parvovirus, 780916 strain, at least ............................................. >103.3 faid50 canine parainfluenza virus, d-008 strain, at least ................................... >103.9 tcid50 canine coronavirus, k-378/51 strain, at least........................................... >103.6 tcid50 "tcid-tissue culture infective dose "faid- fluorescent antibody infective dess lyophilized powder for injection (im/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , canine coronavirus vaccine (ccv) (vet.) - lyophilized powder for injection (im/sc) - each dose 1.0 ml of vaccine contains the following through expiration: active ingredients: canarypox/ canine distemper virus recombinant, cp258, rentschler/onderstepoort strain, at least ................................................................................... >106.4tcid50 canine adenovirus type 2, toronto a/26/61 strain, at least ...................... >104.3 tcid50 canine parvovirus, 780916 strain, at least ............................................. >103.3 faid50 canine parainfluenza virus, d-008 strain, at least ................................... >103.9 tcid50 canine coronavirus, k-378/51 strain, at least........................................... >103.6 tcid50 "tcid-tissue culture infective dose "faid- fluorescent antibody infective dess

Recombitek C6 Each 1.0 mL dose of vaccine contains the following through expiration: Active Ingredients: Canine Distemper, Canarypox Vector .............................................. ≥106.4 TCID50 Canine Adenovirus Type 2 ............................................................. ≥104.3 TCID50 Canine Parainfluenza .................................................................... ≥103.9 TCID50 Canine Parvovirus ........................................................................ ≥103.3 FAID50 Leptospira canicola ....................................................... ≥40 nephelometric units Leptospira icterohaemorrhagiae ...................................... ≥30 nephelometric units *TCID-Tissue Culture Infective Dose **FAID. Fluorescent Antibody Infective Dose ***NTU- Nephelometric Units Lyophilized Powder for Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

recombitek c6 each 1.0 ml dose of vaccine contains the following through expiration: active ingredients: canine distemper, canarypox vector .............................................. ≥106.4 tcid50 canine adenovirus type 2 ............................................................. ≥104.3 tcid50 canine parainfluenza .................................................................... ≥103.9 tcid50 canine parvovirus ........................................................................ ≥103.3 faid50 leptospira canicola ....................................................... ≥40 nephelometric units leptospira icterohaemorrhagiae ...................................... ≥30 nephelometric units *tcid-tissue culture infective dose **faid. fluorescent antibody infective dose ***ntu- nephelometric units lyophilized powder for injection (im/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) vaccine , inactivated leptospira interrogans ser. canicola , leptospira interrogans ser. icterohaemorrhagiae vaccine (vet.) - lyophilized powder for injection (im/sc) - each 1.0 ml dose of vaccine contains the following through expiration: active ingredients: canine distemper, canarypox vector .............................................. ≥106.4 tcid50 canine adenovirus type 2 ............................................................. ≥104.3 tcid50 canine parainfluenza .................................................................... ≥103.9 tcid50 canine parvovirus ........................................................................ ≥103.3 faid50 leptospira canicola ....................................................... ≥40 nephelometric units leptospira icterohaemorrhagiae ...................................... ≥30 nephelometric units *tcid-tissue culture infective dose **faid. fluorescent antibody infective dose ***ntu- nephelometric units

Recombitek C6/CV 1 dose of 1 ml vaccine contains: Lyophilized: Canine Distemper, Canarypox Vector, at least . . . . . . . . . . . . . . . . . . . . . . . 106.4 TCID50 Canine Adenovirus Type 2, Toronto A/26/61 strain, at least. . . . . . . . . . . . 104.3 TCID50 Canine Parainfluenza virus, D-008 strain, at least . . . . . . . . . . . . . . . . . . . 103.9 TCID50 Canine Coronavirus, K-378/51 strain, at least . . . . . . . . . . . . . . . . . . . . . . . 103.6 TCID50 Canine Parvovirus, 780916 strain, at least . . . . . . . . . . . . . . . . . . . . . . . . . . 103.3 FAID50 Liquid: Leptospira canicola, strain 1503, at least . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 NU Leptospira icterohaemorrhagiae, strain 1518, at least. . . . . . . . . . . . . . . . . . 30 NU Lyophilized Powder for Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

recombitek c6/cv 1 dose of 1 ml vaccine contains: lyophilized: canine distemper, canarypox vector, at least . . . . . . . . . . . . . . . . . . . . . . . 106.4 tcid50 canine adenovirus type 2, toronto a/26/61 strain, at least. . . . . . . . . . . . 104.3 tcid50 canine parainfluenza virus, d-008 strain, at least . . . . . . . . . . . . . . . . . . . 103.9 tcid50 canine coronavirus, k-378/51 strain, at least . . . . . . . . . . . . . . . . . . . . . . . 103.6 tcid50 canine parvovirus, 780916 strain, at least . . . . . . . . . . . . . . . . . . . . . . . . . . 103.3 faid50 liquid: leptospira canicola, strain 1503, at least . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 nu leptospira icterohaemorrhagiae, strain 1518, at least. . . . . . . . . . . . . . . . . . 30 nu lyophilized powder for injection (im/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - modified live recombinant canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , canine coronavirus (ccv) , inactivated leptospira interrogans ser. canicola , leptospira interrogans ser. icterohaemorrhagiae vaccine (vet.) - lyophilized powder for injection (im/sc) - 1 dose of 1 ml vaccine contains: lyophilized: canine distemper, canarypox vector, at least . . . . . . . . . . . . . . . . . . . . . . . 106.4 tcid50 canine adenovirus type 2, toronto a/26/61 strain, at least. . . . . . . . . . . . 104.3 tcid50 canine parainfluenza virus, d-008 strain, at least . . . . . . . . . . . . . . . . . . . 103.9 tcid50 canine coronavirus, k-378/51 strain, at least . . . . . . . . . . . . . . . . . . . . . . . 103.6 tcid50 canine parvovirus, 780916 strain, at least . . . . . . . . . . . . . . . . . . . . . . . . . . 103.3 faid50 liquid: leptospira canicola, strain 1503, at least . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 nu leptospira icterohaemorrhagiae, strain 1518, at least. . . . . . . . . . . . . . . . . . 30 nu

Ingelvac MycoFLEX Formulation: Each 1 mL (dose) contains: Mesomycoplasma hyopneumoniae (B-3745 Isolate, J Strain)... >1 RP RP - Relative Potency Emulsion for Injection (IM) Philippines - English - FDA (Food And Drug Administration)

ingelvac mycoflex formulation: each 1 ml (dose) contains: mesomycoplasma hyopneumoniae (b-3745 isolate, j strain)... >1 rp rp - relative potency emulsion for injection (im)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated mesomycoplasma hyopneumoniae vaccine (vet.) - emulsion for injection (im) - formulation: each 1 ml (dose) contains: mesomycoplasma hyopneumoniae (b-3745 isolate, j strain)... >1 rp rp - relative potency

Vaxxitek HVT + IBD + ILT Formulation: Each dose contains: Turkey Herpes Virus, FC-126, Serotype 3 (vHVT317 Strain)..........>5640 PFU Infectious Bursal Disease Virus (VP2 Gene) Infectious Laryngotracheitis Virus (Glycoprotein D) PFU - Plaque Forming Unit Suspension for Injection (In-Ovo/SC) Philippines - English - FDA (Food And Drug Administration)

vaxxitek hvt + ibd + ilt formulation: each dose contains: turkey herpes virus, fc-126, serotype 3 (vhvt317 strain)..........>5640 pfu infectious bursal disease virus (vp2 gene) infectious laryngotracheitis virus (glycoprotein d) pfu - plaque forming unit suspension for injection (in-ovo/sc)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - live recombinant turkey herpesvirus (hvt) , infectious bursal disease (ibd) virus , infectious laryngotracheitis (ilt) virus vaccine (vet.) - suspension for injection (in-ovo/sc) - formulation: each dose contains: turkey herpes virus, fc-126, serotype 3 (vhvt317 strain)..........>5640 pfu infectious bursal disease virus (vp2 gene) infectious laryngotracheitis virus (glycoprotein d) pfu - plaque forming unit

Enterisol Ileitis Each 2 mL of reconstituted vaccine (dose) contains: Lawsonia intracellularis (B3903 strain) *TCID)- Tissue Culture Infective Des 2103.2 TCID50* Lyophilized Powder for Oral Solution Philippines - English - FDA (Food And Drug Administration)

enterisol ileitis each 2 ml of reconstituted vaccine (dose) contains: lawsonia intracellularis (b3903 strain) *tcid)- tissue culture infective des 2103.2 tcid50* lyophilized powder for oral solution

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - live avirulent lawsonia intracellularis vaccine (vet.) - lyophilized powder for oral solution - each 2 ml of reconstituted vaccine (dose) contains: lawsonia intracellularis (b3903 strain) *tcid)- tissue culture infective des 2103.2 tcid50*